Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Maltotetraose (Fujioligo 450) 能够作为生物流体中酶联测定淀粉酶特性的底物。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
5 mg | ¥ 346 | 现货 | ||
10 mg | ¥ 567 | 现货 | ||
25 mg | ¥ 931 | 现货 | ||
50 mg | ¥ 1,396 | 现货 | ||
100 mg | ¥ 1,995 | 现货 |
产品描述 | Maltotetraose (Fujioligo 450) are potent inhibitors of TNF-α-induced intercellular adhesion molecule-1 (ICAM-1) expression, maltotetraose may be beneficial in the suppression of early atherosclerosis development. |
体内活性 | Maltotetraose reduced PDGF-induced sprout formation by mouse aorta explants and inhibited TNF-α-induced NF-κB activation and ICAM-1 expression in MOVAS-1 cells[1]. |
动物实验 | Ex vivo migration of VSMCs was measured by aortic . Mouse thoracic aortas were excised from 8-week-old male Balb/c mice and adipose tissue was removed. The aortas were sectioned into 1-mm–long cross-sections, rinsed with serum-free DMEM, treated with 1 mg/mL collagenenase type II, placed in matrigel-coated wells, covered with 50 uL matrigel, and allowed to gel for more than 30 min at 37℃ in a 5% CO2 atmosphere. The aortic rings were treated with 20 ug/mL MALTOTETRAOSE for 30 min, followed by stimulation with 20 ng/mL PDGF-BB. Aortic ring sprouts were photographed on day 7[1]. |
别名 | Fujioligo 450, Amylotetraose, α-1,4-Tetraglucose, 麦芽四糖 |
分子量 | 666.58 |
分子式 | C24H42O21 |
CAS No. | 34612-38-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (82.51 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.5002 mL | 7.501 mL | 15.002 mL | 37.5049 mL |
5 mM | 0.3 mL | 1.5002 mL | 3.0004 mL | 7.501 mL | |
10 mM | 0.15 mL | 0.7501 mL | 1.5002 mL | 3.7505 mL | |
20 mM | 0.075 mL | 0.375 mL | 0.7501 mL | 1.8752 mL | |
50 mM | 0.03 mL | 0.15 mL | 0.3 mL | 0.7501 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
MALTOTETRAOSE 34612-38-9 Apoptosis Metabolism TNF Endogenous Metabolite Fujioligo-450 Inhibitor Fujioligo 450 inhibit Amylotetraose a-1,4-Tetraglucose α-1,4-Tetraglucose Fujioligo450 alpha-1,4-Tetraglucose 麦芽四糖 inhibitor